<div class="content-intro"><p><span style="text-decoration: underline;"><strong><span data-contrast="auto">Mavericks Wanted</span></strong><span data-ccp-props="{"134233117":true,"134233118":true,"201341983":0,"335559740":240}"> </span></span></p> <p><span data-contrast="auto">When was the last time you achieved the impossible? If that thought feels overwhelming, you might want to pause here, but if it sparks excitement...read on</span> <br><span data-contrast="auto"> </span> <br><span data-contrast="auto">In 2015, we pioneered a “moneyball for biotech” approach, pooling projects and promising early-stage research from academia together under one financial umbrella to reduce risk and unleash innovation. This model allows science and small teams of experts to lead the way. We build bridges to groundbreaking advancements in rare disease, and develop life-changing medicines for patients with unmet needs as fast as humanly possible. </span> <br><span data-contrast="auto"> </span> <br><span data-contrast="auto">Together we define white space, push boundaries, and empower people to solve problems. If you're someone who defies convention, join us and work alongside some of the most respected minds in the industry. Together, we'll ask "why not?" and help reengineer the future of biopharma. At BridgeBio, we value curiosity and experimentation—including the ethical & thoughtful use of AI to improve clarity, speed, and quality of work.</span><span data-ccp-props="{"134233117":true,"134233118":true,"201341983":0,"335559740":240}"> </span></p></div><h3><strong><u>What You’ll Do</u></strong></h3> <p>You will report to the Senior Director, Market Access, EU Center and work closely with Medical Affairs, HEOR, Regulatory, Commercial and our global Market Access team to secure and sustain patient access to BridgeBio’s medicines across the DACH region. Your remit is to own the German AMNOG process end to end – from the value dossier under § 35a SGB V through the reimbursement price negotiation with the National Association of Statutory Health Insurance Funds (GKV-Spitzenverband) under § 130b SGB V – and regional market access, which turns that outcome into real-world access through direct engagement with sickness funds, the Medical Service, regional physicians’ associations, hospitals and treating centres. You will also lead reimbursement submissions in Austria and Switzerland. This role requires effective collaboration with cross-functional colleagues and external stakeholders to ensure high-quality execution and impact. The ideal candidate combines deep AMNOG and HTA expertise with strong communication skills, adaptability, and the ability to thrive in a fast-paced, hands-on environment.</p> <h3><strong><u>Responsibilities</u></strong></h3> <ul> <li><strong>Lead AMNOG value dossiers end to end:</strong> plan, resource, quality-assure and submit complete dossiers under § 35a SGB V to the Federal Joint Committee (G-BA), including derivation of the appropriate comparator therapy (zVT), early identification of evidence gaps and defensible argumentation on indirect comparisons, surrogate and subgroup analyses</li> <li><strong>Own G-BA and IQWiG interactions:</strong> prepare scientific advice requests under § 8 AM-NutzenV, run written commenting procedures and oral hearings, and manage all procedural communication and timelines</li> <li><strong>Prepare and support price negotiations:</strong> develop pricing strategy, negotiation mandate, scenarios and European reference price analyses for the negotiation with the GKV-Spitzenverband under § 130b SGB V, and plan realistically for arbitration board risk</li> <li><strong>Drive regional payer engagement:</strong> engage sickness funds at federal and regional level, the Medical Service (MD) and regional physicians’ associations (KVen) on reimbursement, cost-efficiency reviews and prior-authorisation practice, and translate those insights into regional access concepts</li> <li><strong>Secure hospital and clinic reimbursement:</strong> advise treating centres on NUB applications, DRG and additional-payment (ZE) mapping, budget and price negotiations, drug committees and formulary listing, including outpatient care via ASV under § 116b SGB V</li> <li><strong>Resolve access barriers in the field:</strong> handle individual reimbursement requests, denials and claw-backs together with Medical Affairs and the field teams, and turn recurring issues into argumentation aids and training material</li> <li><strong>Extend access beyond Germany:</strong> lead reimbursement submissions in Austria (EKO) and Switzerland (FOPH Specialities List), and bring market access requirements into study design, evidence planning and launch planning across the cross-functional team</li> </ul> <h3><strong><u>Where You’ll Work </u></strong></h3> <ul> <li>This is a Germany-based remote role</li> <li>Approximately 20% travel is anticipated – for G-BA and GKV-Spitzenverband meetings in Berlin, regional payer and hospital meetings across Germany, selected meetings in Austria and Switzerland, and as-needed visits to our International HQ in Zug</li> </ul> <h3><strong><u>Who You Are</u></strong></h3> <ul> <li>Degree in health economics, pharmacy, medicine, life sciences or a comparable field</li> <li>5–8 years of experience in market access or HTA – in the pharmaceutical industr